Literature DB >> 24293306

Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure.

Richard Lowrie1, Lina Johansson, Paul Forsyth, Stuart Lochhead Bryce, Susan McKellar, Niamh Fitzgerald.   

Abstract

BACKGROUND: Heart failure (HF) is common, disabling and deadly. Patients with HF often have poor self-care and medicines non-adherence, which contributes to poor outcomes. Community pharmacy based cognitive services have the potential to help, but we do not know how patients view community-pharmacist-led services for patients with HF.
OBJECTIVE: We aimed to explore and portray in detail, the perspectives of patients receiving, and pharmacists delivering an enhanced, pay for performance community pharmacy HF service.
SETTING: Community pharmacies and community-based patients in Greater Glasgow and Clyde, Scotland.
METHODS: Focus groups with pharmacists and semi-structured interviews with individual patients by telephone. Cross sectional thematic analysis of qualitative data used Normalization Process Theory to understand and describe patient's reports. MAIN OUTCOME MEASURE: Experiences of receiving and delivering an enhanced HF service.
RESULTS: Pharmacists voiced their confidence in delivering the service and highlighted valued aspects including the structured consultation and repeated contacts with patients enabling the opportunity to improve self care and medicines adherence. Discussing co-morbidities other than HF was difficult and persuading patients to modify behaviour was challenging. Patients were comfortable discussing symptoms and medicines with pharmacists; they identified pharmacists as fulfilling roles that were needed but not currently addressed. Patients reported the service helped them to enact HF medicines and HF self care management strategies.
CONCLUSION: Both patients receiving and pharmacists delivering a cognitive HF service felt that it addressed a shortfall in current care. There may be a clearly defined role for pharmacists in supporting patients to address the burden of understanding and managing their condition and treatment, leading to better self management and medicines adherence. This study may inform the development of strategies or policies to improve the process of care for patients with HF and has implications for the development of other extended role services.

Entities:  

Mesh:

Year:  2013        PMID: 24293306     DOI: 10.1007/s11096-013-9889-2

Source DB:  PubMed          Journal:  Int J Clin Pharm


  39 in total

1.  Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.

Authors:  Richard Lowrie; Frances S Mair; Nicola Greenlaw; Paul Forsyth; Pardeep S Jhund; Alex McConnachie; Brian Rae; John J V McMurray
Journal:  Eur Heart J       Date:  2011-11-14       Impact factor: 29.983

Review 2.  Interventions to enhance adherence to medications in patients with heart failure: a systematic review.

Authors:  Gerard J Molloy; Ronan E O'Carroll; Miles D Witham; Marion E T McMurdo
Journal:  Circ Heart Fail       Date:  2012-01       Impact factor: 8.790

Review 3.  Successes and failures of current treatment of heart failure.

Authors:  J G Cleland; K Swedberg; P A Poole-Wilson
Journal:  Lancet       Date:  1998-08       Impact factor: 79.321

4.  Analysis of pharmacist-patient communication using the Calgary-Cambridge guide.

Authors:  Nicola Greenhill; Claire Anderson; Anthony Avery; Alison Pilnick
Journal:  Patient Educ Couns       Date:  2011-06-02

Review 5.  Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure.

Authors:  Karen E Joynt; David J Whellan; Christopher M O'connor
Journal:  J Card Fail       Date:  2004-06       Impact factor: 5.712

6.  Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.

Authors:  Sayed H Naderi; Jonathan P Bestwick; David S Wald
Journal:  Am J Med       Date:  2012-06-27       Impact factor: 4.965

7.  Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF).

Authors:  Amrut V Ambardekar; Gregg C Fonarow; Adrian F Hernandez; Wenqin Pan; Clyde W Yancy; Mori J Krantz
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

8.  Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.

Authors:  F D R Hobbs; J E Kenkre; A K Roalfe; R C Davis; R Hare; M K Davies
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

9.  Evidence-based medicine and patient choice: the case of heart failure care.

Authors:  Tom Sanders; Stephen Harrison; Kath Checkland
Journal:  J Health Serv Res Policy       Date:  2008-04

10.  Descriptions of barriers to self-care by persons with comorbid chronic diseases.

Authors:  Elizabeth A Bayliss; John F Steiner; Douglas H Fernald; Lori A Crane; Deborah S Main
Journal:  Ann Fam Med       Date:  2003 May-Jun       Impact factor: 5.166

View more
  12 in total

1.  Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.

Authors:  Julien Marquis; Marie P Schneider; Brenda Spencer; Olivier Bugnon; Sophie Du Pasquier
Journal:  Int J Clin Pharm       Date:  2014-08-20

2.  Patient Self-management in Chronic Heart Failure - Establishing Concordance Between Guidelines and Practice.

Authors:  Samia R Toukhsati; Andrea Driscoll; David L Hare
Journal:  Card Fail Rev       Date:  2015-10

Review 3.  Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure.

Authors:  Daya Ram Parajuli; Julie Franzon; Ross A McKinnon; Sepehr Shakib; Robyn A Clark
Journal:  Curr Heart Fail Rep       Date:  2017-04

Review 4.  The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy.

Authors:  Lucianne M West; J Bradley Williams; Kathleen D Faulkenberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-10

5.  Applying lean methodology to improve parenteral chemotherapy and monoclonal antibody documentation processes based on Normalisation Process Theory.

Authors:  Lorna Marie West; Alison Brincat; Mark Mercieca; Demis Fsadni; Ian Rapa; Maria Cordina
Journal:  Eur J Hosp Pharm       Date:  2017-01-02

6.  Self-care of long-term conditions: patients' perspectives and their (limited) use of community pharmacies.

Authors:  Oladapo J Ogunbayo; Ellen I Schafheutle; Christopher Cutts; Peter R Noyce
Journal:  Int J Clin Pharm       Date:  2017-01-24

7.  Using Normalization Process Theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review.

Authors:  Carl R May; Amanda Cummings; Melissa Girling; Mike Bracher; Frances S Mair; Christine M May; Elizabeth Murray; Michelle Myall; Tim Rapley; Tracy Finch
Journal:  Implement Sci       Date:  2018-06-07       Impact factor: 7.327

8.  Towards equity: a qualitative exploration of the implementation and impact of a digital educational intervention for pharmacy professionals in England.

Authors:  Asam Latif; Justin Waring; Kristian Pollock; Josie Solomon; Nargis Gulzar; Shahida Choudhary; Claire Anderson
Journal:  Int J Equity Health       Date:  2019-10-12

Review 9.  A Review of the Role of the Pharmacist in Heart Failure Transition of Care.

Authors:  Sarah L Anderson; Joel C Marrs
Journal:  Adv Ther       Date:  2018-02-27       Impact factor: 3.845

10.  Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review.

Authors:  Ali M K Hindi; Ellen I Schafheutle; Sally Jacobs
Journal:  Health Expect       Date:  2017-11-08       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.